Malcisbo AG
PrivateLast Round
Seed
Sep 19, 2011
Total Funding Raised
$4.33M
Company Overview
Malcisbo AG is a biotechnology company that develops carbohydrate-based veterinary vaccines using a novel glycoengineering platform to prevent bacterial infections in farm animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Malcisbo AG Comparables
Compare Malcisbo AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VaxAlta Inc. | 90% | |
| ArkVax | 88% | |
| Santella AG | 80% | |
Malcisbo AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 19, 2011 | ||||
| Accelerator | Nov 9, 2010 | ||||
| Grant | Jun 8, 2010 |
Malcisbo AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redalpine | Seed |
| Venture Kick | Grant, Accelerator |
| Zurcher Kantonalbank | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2010
$130K raised from Venture Kick
Malcisbo AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Malcisbo AG's valuation, stock price, and market status.